Your browser doesn't support javascript.
loading
Why does Pharmac neglect inflammatory bowel disease?
McCombie, Andrew; Arnold, Malcolm; O'Connor, Marian; Stein, Richard; Fulforth, James; Brown, Belinda; Gearry, Richard.
Afiliação
  • McCombie A; Research Officer and Data Analyst, Department of General Surgery, Canterbury District Health Board; Honorary Senior Research Fellow, University of Otago, Christchurch; Executive Committee Elected Member, New Zealand Society of Gastroenterology.
  • Arnold M; Consultant Gastroenterologist, Department of Gastroenterology, Canterbury District Health Board; President of the New Zealand Society of Gastroenterology.
  • O'Connor M; Clinical Nurse Specialist, Taranaki District Health Board; Co-chair of the NZ IBD Nursing Group, GENCA Board Director.
  • Stein R; Chairman, Crohn's and Colitis New Zealand Charitable Trust; Clinical Senior Lecturer, University of Otago, Wellington.
  • Fulforth J; Consultant Gastroenterologist, Department of Gastroenterology, Waikato District Health Board.
  • Brown B; Operations Manager, Crohn's and Colitis New Zealand Charitable Trust.
  • Gearry R; Consultant Gastroenterologist, Department of Gastroenterology, Canterbury District Health Board; Head of Department, Department of Medicine, University of Otago, Christchurch.
N Z Med J ; 133(1527): 111-115, 2020 12 18.
Article em En | MEDLINE | ID: mdl-33332333
Buscar no Google
Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Colite Ulcerativa / Doença de Crohn / Aprovação de Drogas / Órgãos Governamentais Limite: Humans País como assunto: Oceania Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Colite Ulcerativa / Doença de Crohn / Aprovação de Drogas / Órgãos Governamentais Limite: Humans País como assunto: Oceania Idioma: En Ano de publicação: 2020 Tipo de documento: Article